miRNA-467b inhibits Th17 differentiation by targeting eIF4E in experimental autoimmune encephalomyelitis

Ting Wu1, Yunxuan Lei2, Shuxin Jin2

  • 1Department of Immunology and Microbiology, Shanghai JiaoTong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China; RenJi(North) Hospital Shanghai Jiaotong University School of Medicine, Shanghai 200135, China.

Molecular Immunology
|February 23, 2021
PubMed

Insights

MicroRNA-467b suppresses T-helper 17 cell differentiation by targeting eIF4E, alleviating experimental autoimmune encephalomyelitis (EAE) severity. This finding offers a potential therapeutic strategy for neuroinflammatory diseases like multiple sclerosis (MS).

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Autoimmune Diseases

Background:

  • Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) are characterized by central nervous system inflammation, demyelination, and neurodegeneration.
  • Overactivated CD4+ T cells, particularly Th1 and Th17 subsets, drive neuroinflammation and subsequent neurological deficits in EAE.
  • Understanding the regulatory mechanisms of T-cell differentiation is crucial for developing MS therapies.

Purpose of the Study:

  • To investigate the role of microRNA-467b (miRNA-467b) in regulating T-helper (Th) cell development in the context of EAE.
  • To elucidate the molecular targets and functional consequences of miRNA-467b in EAE pathogenesis.

Main Methods:

  • Quantitative analysis of miRNA-467b and eukaryotic initiation factor 4F (eIF4E) levels in EAE mice.
  • In vitro studies involving overexpression of miRNA-467b in CD4+ T cells to assess its effect on Th17 differentiation.
  • In vivo administration of miRNA-467b mimics in EAE mice to evaluate therapeutic potential.

Main Results:

  • miRNA-467b levels were decreased, while eIF4E levels were increased in the lymph nodes and CNS during peak EAE.
  • eIF4E was identified as a direct target of miRNA-467b.
  • Overexpression of miRNA-467b suppressed CD4+ IL-17+ cell populations and Th17 cell differentiation in vitro.
  • Administration of miRNA-467b mimics reduced inflammation and alleviated disease severity in EAE mice.

Conclusions:

  • miRNA-467b acts as a negative regulator of Th17 cell differentiation and function by targeting eIF4E.
  • Restoring miRNA-467b levels can ameliorate EAE, suggesting its therapeutic potential for MS and related neuroinflammatory conditions.